Even from a single source plant,
new industries emerge

1. Next-Generation Probiotics Discovery Platform

Even when a single plant is put through the VPMI-GRBM process, Vital Probiotics can be reconstituted, through interaction with the plant and horizontal gene transfer, into strain groups that have acquired new functional genetic information. These strains may have ecological functions different from existing commercial probiotics, and AI analysis creates new value. GRBM can become the source platform of an entirely new ecological functional probiotics industry.

• Functional strain libraries and gene and function marker mapping by strain
• Exploring next-generation probiotics for gut health, immune balance, organ-function preservation and metabolic support
• Plant-specific probiotics discovery
• Strain licensing, B2B strain supply and microbiome-based companion products

2. Pet Care — Mammalian Companion Health Platform

GRBM can be applied not only to people but to most mammals. The global pet-care market is premiumizing fast, moving from basic feed to functional nutrition, gut health, healthy ageing and pet microbiome care.

• Gut-health supplements for dogs; recovery-oriented functional foods for cats
• Topical care for skin and coat health
• Healthy-ageing support for older companion animals
• Personalized pet microbiome nutrition and supportive-care foods for recovery

3. Livestock Health & Antibiotic-Reduction Solutions

The residual plant bioactive mass left after the GRBM process is not waste but a secondary bio-resource for livestock health. It has two strengths: a circular bio-economy and sustainable livestock farming (ESG).

• Health supplements for cattle, sheep, pigs and other livestock
• Feed supplements that reduce dependence on antibiotics
• Support for gut health and metabolic stability; aids for stress relief and animal welfare
• A circular livestock–bio-resource model

4. Plant Health & Ecological Crop Health Platform

Climate change is altering the quality, phytochemical profiles and microbial interactions of fruits, vegetables and crops. Changes in the microbes that interact with plants strongly affect plants' functionality, safety and benefit. GRBM can go beyond a technology that consumes plants to an upstream agricultural bio-platform that produces healthier plants themselves.

• Managing plant microbiomes during cultivation; ecological control of microbes involved in horizontal gene exchange
• Support for high-functional crop production; microbiome interventions for plants more beneficial to people
• Functional microbial solutions for smart farms; climate-resilient bio-farming inputs

5. Ecological Antiviral Plant Defense Platform

The concept is to observe the defensive bio-substances plants produce under a specific RNA-virus challenge, and to reproduce, amplify and produce that counter-mechanism on a GRBM/VPMI basis, developing ecological and safe plant-derived antiviral defence resources. The deep-tech option value here is greater than immediate commercialization.

• Agricultural bio-protectants and plant immune-activating substances
• AI-based discovery of plant defence molecules
• Nature-based antiviral plant materials; source materials for disease-control research

6. Advanced Phytochemical Development

Making GRBM from deeply coloured or specific functional plants and then separating, purifying and extracting it leads to a platform for producing low-molecular, advanced phytochemicals. GRBM already holds a staged industrial path: "selling base liquids → productization → refined materials → high-purity candidate substances".

• The potential for better phytochemical bioavailability based on the metabolome
• A predictable production structure that includes the precursor stage
• Pigment, antioxidant, anti-inflammatory and functional cosmetic materials shared across food, nutrition and drug-candidate uses
• A mass-producible standardized bioactive library

7. Mass Consumer Functional Foods & Beverages

GRBM extends not only to high-function, high-value products but also to mass-distribution foods. This area builds a brand ladder that links premium medical and service platforms with everyday consumer markets.

• GRBM ice cream — a mass-premium dessert that lowers the barrier to eating while keeping a functional image; functional desserts for children; possible frozen snacks for pets
• Metabolized Coffee — fresh beans metabolized to refine flavour and the amino-acid profile and improve the felt balance of caffeine stimulation
• GRBM Tea and Cold Botanical Drinks — GRBM itself as an everyday daily metabolic tea drink

8. Well-Dying — Metabolic Dignity Framework

Existing senior industries and medical services sometimes focus on drug-, ventilator- and life-prolonging-centred care. By giving human cells and tissues a more comfortable metabolic environment, GRBM can extend into a new supportive-care framework that pursues metabolic comfort, nutritional support and dignity-oriented care even in life's final stage. It also connects with the High Level Service.

• Supportive care in older adults' recovery and metabolic supportive care before the terminal stage
• Quality-of-life-centred care and family-centred caregiving
• A care philosophy that reaches the final stage of "Life Re:Design"

Because this area carries major ethical and legal issues, it is approached strictly as "supportive care", not "treatment", and as "dignity-oriented end-of-life support", not "assisted death".

From one theory to many industries — stages

Collaboration history and interest

According to company records from the first-generation technology (lactobacilli low-salt kimchi), the company took part in developing a core ingredient for CHANEL's camellia cosmetics, collaborated with GC Green Cross on lactobacilli-based health functional foods, and Nestlé has shown interest in low-salt-kimchi-based baby food and liquid diets. Industrialization technology has been completed, and full-scale investment is under way. Detailed records are at www.gimchi.biz.

About 50 pipelines

The company plans about 50 business pipelines across foods, drinks, protein, kimchi, smoothies, cosmetics, ingredients, services, data and drug candidates. Each pipeline is designed so that rights can be divided by region and use for partnership; details are provided after an NDA.

Request pipeline materials →

Collaboration history is a record of cooperation and interest according to company records and does not imply endorsement by, or a current contract with, any of these companies. Expansion areas are business plans presented by the company; the effects in each area will go through separate research and validation.